BEVAZAME Trademark

Trademark Overview


On Monday, December 14, 2020, a trademark application was filed for BEVAZAME with the United States Patent and Trademark Office. The USPTO has given the BEVAZAME trademark a serial number of 90381374. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 20, 2022. This trademark is owned by Pfizer Inc.. The BEVAZAME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
bevazame

General Information


Serial Number90381374
Word MarkBEVAZAME
Filing DateMonday, December 14, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 20, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, June 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 20, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, August 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 13, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 28, 2021NON-FINAL ACTION E-MAILED
Wednesday, April 28, 2021NON-FINAL ACTION WRITTEN
Wednesday, April 21, 2021ASSIGNED TO EXAMINER
Monday, February 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 17, 2020NEW APPLICATION ENTERED IN TRAM